[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507555":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":35,"collaborators":39,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":72,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Chinese PLA General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Type 2 diabetic nephropathy",null,"The cohort will be divided into 2 or 3 groups according the pathological results of patients,and at least 3 groups according to clinical features such as renal function and proteinuria.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Zheyi Dong, MD","CONTACT","+86 010 66935462","shengdai26@163.com",[19],{"facility":5,"status":20,"city":21,"state":10,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Beijing","100853","China","CN",{"type":26,"coordinates":27},"Point",[28,29],116.39723,39.9075,{"lat":29,"lon":28},[32],{"name":33,"role":15,"phone":16,"phoneExt":10,"email":34},"Xiangmei Chen, MD.&Ph.D","xmchen301@126.com",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Xiangmei Chen","Professor,Chief physician,Academician of Chinese Academy of Engineering",[40,42,44,46,48,51,53],{"name":41,"class":6},"Beijing Municipal Science & Technology Commission",{"name":43,"class":6},"China-Japan Friendship Hospital",{"name":45,"class":6},"Beijing Friendship Hospital",{"name":47,"class":6},"Beijing Tongren Hospital",{"name":49,"class":50},"Beijing Hospital","OTHER_GOV",{"name":52,"class":6},"Dongzhimen Hospital, Beijing",{"name":54,"class":6},"Xuanwu Hospital, Beijing","100507555","multidimensional-accurate-diagnosis-and-treatment-technology-and-clinical-transformation-of-type-2-diabetes-nephropathy-100507555",false,"NCT05888909","Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy","Inclusion Criteria:\n\nAge ≥ 18 years old, regardless of gender; Type 2 diabetes; Having a complete medical history and clinical data; If the patients with type 2 diabetes combined with CKD underwent renal biopsy, the pathological diagnosis should be clear; Patients voluntarily signs an informed consent form.\n\nExclusion criteria:\n\nIncomplete medical history or clinical data; Patients with hereditary kidney disease; Combined urinary tract infection; Merge autoimmune system diseases; Patients with malignant tumor were expected to survive less than 6 months; Pregnancy and lactation.","ALL","18 Years",{"count":64,"type":65},2000,"ESTIMATED","OBSERVATIONAL","Diabetes nephropathy (DN) is one of the most serious microvascular complications of diabetes, and also an important cause of death and disability of diabetes patients. There is no specific clinical staging of type 2 diabetes nephropathy at home and abroad, and there is no comprehensive study to comprehensively describe the occurrence and development of type 2 diabetes nephropathy through sensitive biomarkers, microvascular disease imaging and functional detection, digital markers and other multi-dimensional diagnosis and evaluation methods. Therefore, our research aims to establish a long-term follow-up queue for the whole cycle of diabetes nephropathy, develop multi-dimensional diagnostic and progress digital markers for diabetes nephropathy, develop a multimodal non-invasive diagnostic model and a new clinical staging\u002Ftyping, and create a multi-dimensional accurate diagnosis and treatment system for type 2 diabetes nephropathy combining traditional Chinese and western medicine.",[69,70,71],"Diabetic Nephropathy Type 2","Diabetic Kidney Disease","Type 2 Diabetes",[69,70,71,73,74],"Diagnosis","Treatment","2023-05-25",{"date":77,"type":78},"2023-06-05","ACTUAL",{"date":80,"type":78},"2022-08-01",{"date":82,"type":65},"2026-12-31",{"name":5,"class":6},1]